Overview

LYR-210 Depot (LYR-210) for Adult Subjects With Chronic Sinusitis (LANTERN Study)

Status:
Unknown status
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
This is a Phase II, Randomized, Blinded, Sham Procedure-Controlled, Parallel-Group Trial to Evaluate the Efficacy, Safety and Tolerability of LYR-210 in Adult Subjects with Chronic Sinusitis.
Phase:
Phase 2
Details
Lead Sponsor:
Lyra Therapeutics
Treatments:
Mometasone Furoate